Radiation oncology

Department of Radiation Oncology, Department of Pediatrics, St. Louis Children s Hospital, Washington University School of Medicine,... [Pg.1]

Heron, D. E., Andrade, R. S., Flickinger, J. et al. Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers a brief technical report. Int. J. Radiation Oncology Biol. Phys., 60 1419-1424,2004. [Pg.960]

Corti L, Skarlatos J, Boso C, Cardin F, Kosma L, Koukourakis MI, Giatromanolaki A, Norberto L, Shaffer M, Beroukas K (2000) Outcome of patients receiving photodynamic therapy for early esophageal cancer. International Journal of Radiation Oncology Biology Physics 47 419 124. [Pg.259]

Notes Department of Radiation Oncology, Wake Forest University School... [Pg.484]

Phillips T. Biochemical Modifiers Drug-Radiation Interactions. In Mauch PM, Loeffler JS, eds. Radiation Oncology Technology and Biology. Philadelphia WB Saunders Company 1994. pp. 113-152. [Pg.20]

A randomized study comparing carboplatin/5-FU/radiotherapy vs radiotherapy in patients with locally advanced oropharyngeal carcinoma was recently reported by the French Group of Radiation Oncology for HNC (GORTEC) (54). Two hundred twenty-six patients were randomized to conventional radiotherapy or identical radiotherapy combined with three cycles of the 4-d regimen of carboplatin (70 mg/m2/d) and continuous infusion 5-FU (600 mg/m2/d) on d 1,22, and 43 of radiation. Increased mucositis was reported in the combined modality arm 67% vs 36%. No difference in skin toxicity was... [Pg.155]

Gy in favorable patients with radiation oncology group stage III non small cell lung carcinoma Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990 8 1543-1555. [Pg.191]

Localized cancers are not often treated using a single modality. Rather, they are approached in a multidisciplinary manner. This approach has evolved over the past 15 yr to include medicine, surgery, radiation oncology, and gastroenterology. [Pg.253]

Sauer R, Schrott KM, Dunst J, Thiel H-J, Hermanek P, Bomhof C. Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cisplatin. Int J Radiation Oncology Biol Phys 1988 15 871-875. [Pg.301]

Lichter AS, Lawrence TS. Recent advances in radiation oncology. N Engl J Med 1995 332 371-379. [Pg.334]

Department of Radiation Oncology Vanderbilt University Medical Center Nashville, Tennessee... [Pg.425]

Roger W. Byhardt Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI... [Pg.433]

Bapsi Chak Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN... [Pg.433]

Walter J. Curran, Jr. Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA Heather A. Curry Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA... [Pg.433]

Silvia C. Formenti Department of Radiation Oncology, New York University School of Medicine, New York, NY Elora Gupta Bristol-Myers Squibb, Wallingford, CT... [Pg.433]

Hong Pyo Yonsei University College of Medicine, Seodaemun-KU, Seoul, Korea Tyvin A. Rich Department of Radiation Oncology, The University of Virginia Health System, Charlottesville, VA... [Pg.434]

Christopher G. Willett Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA... [Pg.434]

Gary Yang Division of Radiation Oncology, The Johns Hopkins Oncology Center, Baltimore, MD... [Pg.434]

In the radiation oncology (or radiobiology) community, hadron therapy currently includes the application of protons, helium, carbon, neon, and argon ions. Carbon, neon, or argon ions are called heavy ions, while protons and helium ions are called light ions. In contrast, in the physics community, all ions mentioned above are called light ions compared to much heavier ions such as, for example, uranium [43]. [Pg.767]

SUMMARY AND CONCLUSIONS PRESENT TRENDS AND EXPECTATIONS IN RADIATION ONCOLOGY... [Pg.778]

OTTO A. GANSOW—Inorganic and Radioimmune Chemistry Section, Radiation Oncology Branch, Division of Cancer Treatment, National Cancer Institute and Laboratory of Chemical Physics, National Institute of Arthritis, Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, MD 20205... [Pg.215]

Gray Institute for Radiation Oncology and Biology, University of Oxford 2Laboratoire de Chimie de Coordination, Centre National de la Recherche Scientifique, Universite de Toulouse... [Pg.153]

Molls M, Vaupel P (1998) The impact of the tumor environment on experimental and clinical radiation oncology and other therapeutic modalities. In Molls M, Vaupel P (eds) Blood perfusion and microenvironment of human tumors - implications for clinical radiooncology. Springer, Berlin Heidelberg New York... [Pg.87]

Rosenthal, D.I. et al. (2000) Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin, Department of Radiation Oncology, University of Pennsylvania Medical Center, Philadelphia 19104-4283, USA, 593-598. [Pg.423]

Department of Chemistry, University College London, 20 Gordon Street, London, WC1H OAJ Department of Chemistry, A1 I Cuza University of Iasi, Bd. Carol I, 11, Iasi 700506, Romania Gray Institute for Radiation Oncology and Biology - University of Oxford, Old Road Campus Research Building, Churchill Hospital, Oxford, OX3 7DQ... [Pg.589]

Gerweck, L.E., Koutcher, J.A., Zaidi, S.T.H., Seneviratne, T. (1992). Energy status in the murine FSall and MCaTV tumors under aerobic and hypoxic conditions An in-vivo and in-vitro analysis. Int. J. Radiation Oncology Biol. Phys. 23,557-561. [Pg.265]

Medical Radiology Diagnostic Imaging and Radiation Oncology Series Editors A. L. Baert L. W. Brady H.-R Heilmann M. Molls K. Sartor... [Pg.308]

Lee j, McKenna R et al. (2001) Non-small cell lung cancer, mesothelioma and thymoma. In Pazdur R, Coia L, Hoskins W, Wagman L (eds) Cancer Management A Multidisciplinary Approach - MedicalSurgical and Radiation Oncology. Melville, NY PRR Inc., pp. 87-125. [Pg.172]

Raleigh JA, Franko AJ, Treiber EO et al (1986) Int J Radiation Oncology Biol Phys 12 1243-1245... [Pg.382]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...